As millions of people and thousands of clinicians begin using general-purpose AI tools (such as ChatGPT, Grok, Gemini, and others) for medical questions and image interpretation, new case reports and peer-reviewed studies show these systems can confidently produce convincing but false medical information — in some cases directly misleading patients and contributing to harm.
As millions of people and thousands of clinicians begin using general-purpose AI tools (such as ChatGPT, Grok, Gemini, and others) for medical questions and image interpretation, new case reports and peer-reviewed studies show these systems can confidently produce convincing but false medical information – in some cases directly misleading patients and contributing to harm.
As millions of people and thousands of clinicians begin using general-purpose AI tools (such as ChatGPT, Grok, Gemini, and others) for medical questions and image interpretation, new case reports and peer-reviewed studies show these systems can confidently produce convincing but false medical information — in some cases directly misleading patients and contributing to harm.
As millions of people and thousands of clinicians begin using general-purpose AI tools (such as ChatGPT, Grok, Gemini, and others) for medical questions and image interpretation, new case reports and peer-reviewed studies show these systems can confidently produce convincing but false medical information — in some cases directly misleading patients and contributing to harm.
As millions of people and thousands of clinicians begin using general-purpose AI tools (such as ChatGPT, Grok, Gemini, and others) for medical questions and image interpretation, new case reports and peer-reviewed studies show these systems can confidently produce convincing but false medical information — in some cases directly misleading patients and contributing to harm.
Doctoral student Ishita Kathuria was influenced by her family’s history of heart disease to pursue cardiovascular research.
The recombinant herpes zoster vaccine is effective in older adults regardless of a patient’s immunocompromised status, based on data from more than 3 million adults aged 65 years or older.
A recent graduate from the University of Arkansas (UA) at Little Rock used a $4,000 grant to study how bulimia affects teeth.
